The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Endothelial Function in Human Immunodeficiency Virus-Infected Antiretroviral-Naive Subjects Before and After Starting Potent Antiretroviral Therapy
Open accessAbstract
Objectives This study evaluated the effects of three class-sparing antiretroviral therapy (ART) regimens on endothelial function in HIV-infected subjects participating in a randomized trial. Background Endothelial dysfunction has been observed in patients receiving ART for human immunodeficiency virus (HIV) infection. Methods This was a prospective, multicenter study of treatment-naïve subjects who were randomly assigned to receive a protease inhibitor-sparing regimen of nucleoside reverse transcriptase inhibitors (NRTIs) + efavirenz, a non-nucleoside reverse transcriptase inhibitor-sparing regimen of NRTIs + lopinavir/ritonavir, or a NRTI-sparing regimen of efavirenz + lopinavir/ritonavir. NRTIs were lamivudine + stavudine, zidovudine, or tenofovir. Brachial artery flow-mediated dilation (FMD) was determined by B-mode ultrasound before starting on ART, then after 4 and 24 weeks. Results There were 82 subjects (median age 35 years, 91% men, 54% white). Baseline CD4 cell counts and plasma HIV RNA values were 245 cells/mm3 and 4.8 log10 copies/ml, respectively. At baseline, FMD was 3.68% (interquartile range 1.98 – 5.51%). After 4 and 24 weeks of ART, plasma HIV RNA decreased by 2.1 and 3.0 log10 copies/mL, respectively. FMD increased by 0.74% (−0.62 – +2.74, p=0.003) and 1.48% (−0.20 – +4.30%, p< 0.001), respectively, with similar changes in each arm (pKW>0.600). The decrease in plasma HIV RNA at 24 weeks was associated with greater FMD (rs=− 0.30, p=0.017). Conclusions Among treatment-naïve individuals with HIV, three different ART regimens rapidly improved endothelial function. Benefits were similar for all ART regimens, appeared quickly, and persisted at 24 weeks. Condensed Abstract Among 82 treatment-naïve HIV-infected subjects participating in a prospective, multicenter study of three class-sparing antiretroviral therapy regimens, flow-mediated dilation of the brachial artery improved after 4 (+0.74%, p=0.003) and 24 weeks (+1.48%, p< 0.001), with similar changes in each arm (pKW>0.600).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
STATISTICAL METHODS FOR ASSESSING AGREEMENT BETWEEN TWO METHODS OF CLINICAL MEASUREMENT
Martin Bland, J., & Altman, D. (1986) · The Lancet · doi:10.1016/s0140-6736(86)90837-8 · Cited by 47,965
(1965) · The Lancet · doi:10.1016/s0140-6736(65)91037-8 · Cited by 16,856
Palella, F. J., Delaney, K. M., Moorman, A. C., Loveless, M. O., Fuhrer, J., Satten, G. A., Aschman, D. J., & Holmberg, S. D. (1998) · New England Journal of Medicine · doi:10.1056/nejm199803263381301 · Cited by 9,405
Corretti, M. C., Anderson, T. J., Benjamin, E. J., Celermajer, D., Charbonneau, F., Creager, M. A., Deanfield, J., Drexler, H., Gerhard-Herman, M., Herrington, D., et al. (2002) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(01)01746-6 · Cited by 4,604
Endothelial Function and Dysfunction: Testing and Clinical Relevance
Deanfield, J. E., Halcox, J. P., & Rabelink, T. J. (2007) · Circulation · doi:10.1161/circulationaha.106.652859 · Cited by 2,710
CD4+ Count–Guided Interruption of Antiretroviral Treatment
(2006) · New England Journal of Medicine · doi:10.1056/nejmoa062360 · Cited by 2,231
Triant, V. A., Lee, H., Hadigan, C., & Grinspoon, S. K. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-2190 · Cited by 1,613
Class of Antiretroviral Drugs and the Risk of Myocardial Infarction
(2007) · New England Journal of Medicine · doi:10.1056/nejmoa062744 · Cited by 1,521
American Society of Echocardiography recommendations for use of echocardiography in clinical trials
Gottdiener, J. S., Bednarz, J., Devereux, R., Gardin, J., Klein, A., Manning, W. J., Morehead, A., Kitzman, D., Oh, J., Quinones, M., et al. (2004) · Journal of the American Society of Echocardiography · doi:10.1016/j.echo.2004.07.013 · Cited by 902
Self-citationYeboah, J., Crouse, J. R., Hsu, F.-C., Burke, G. L., & Herrington, D. M. (2007) · Circulation · doi:10.1161/circulationaha.106.678276 · Cited by 891
Sorensen, K. E., Celermajer, D. S., Spiegelhalter, D. J., Georgakopoulos, D., Robinson, J., Thomas, O., & Deanfield, J. E. (1995) · Heart · doi:10.1136/hrt.74.3.247 · Cited by 694
Class-Sparing Regimens for Initial Treatment of HIV-1 Infection
Riddler, S. A., Haubrich, R., DiRienzo, A. G., Peeples, L., Powderly, W. G., Klingman, K. L., Garren, K. W., George, T., Rooney, J. F., Brizz, B., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa074609 · Cited by 680
Self-citationBozzette, S. A., Ake, C. F., Tam, H. K., Chang, S. W., & Louis, T. A. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022048 · Cited by 625
Stein, J. H., Klein, M. A., Bellehumeur, J. L., McBride, P. E., Wiebe, D. A., Otvos, J. D., & Sosman, J. M. (2001) · Circulation · doi:10.1161/01.cir.104.3.257 · Cited by 479
Self-citationObel, N., Thomsen, H. F., Kronborg, G., Larsen, C. S., Hildebrandt, P. R., Sorensen, H. T., & Gerstoft, J. (2007) · Clinical Infectious Diseases · doi:10.1086/518285 · Cited by 331
Wolf, K., Tsakiris, D. A., Weber, R., Erb, P., Battegay, M., & Study, S. H. C. (2002) · The Journal of Infectious Diseases · doi:10.1086/338572 · Cited by 234
Endothelial Function in HIV-Infected Persons
Solages, A., Vita, J. A., Thornton, D. J., Murray, J., Heeren, T., Craven, D. E., & Horsburgh, C. R. (2006) · Clinical Infectious Diseases · doi:10.1086/503261 · Cited by 208
Charakida, M., Donald, A. E., Green, H., Storry, C., Clapson, M., Caslake, M., Dunn, D. T., Halcox, J. P., Gibb, D. M., Klein, N. J., et al. (2005) · Circulation · doi:10.1161/circulationaha.104.517144 · Cited by 172
HIV Protease Inhibitor Ritonavir Induces Cytotoxicity of Human Endothelial Cells
Zhong, D.-S., Lu, X.-H., Conklin, B. S., Lin, P. H., Lumsden, A. B., Yao, Q. C., & Chen, C. (2002) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000034707.40046.02 · Cited by 135
Molecular Mechanisms of HIV Protease Inhibitor-Induced Endothelial Dysfunction
Wang, X., Chai, H., Yao, Q. C., & Chen, C. (2007) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e3180322542 · Cited by 133
van Wijk, J. P. H., de Koning, E. J. P., Cabezas, M. C., Joven, J., Roodt, J. O. ’., Rabelink, T. J., & Hoepelman, A. I. M. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.09.073 · Cited by 115
Zietz, C., Hotz, B., Stürzl, M., et al. (1996) · PubMed · Cited by 114
Ly, H. Q., Denault, A. Y., Dupuis, J., Vadeboncœur, A., Harel, F., Arsenault, A., Gibson, C. M., & Bonan, R. (2005) · American Heart Journal · doi:10.1016/j.ahj.2005.02.049 · Cited by 95
Indinavir impairs endothelial function in healthy HIV-negative men
Shankar, S. S., Dubé, M. P., Gorski, J. C., Klaunig, J. E., & Steinberg, H. O. (2005) · American Heart Journal · doi:10.1016/j.ahj.2005.06.005 · Cited by 93
Self-citationBlum, A., Hadas, V., Burke, M., Yust, I., & Kessler, A. (2005) · Clinical Cardiology · doi:10.1002/clc.4960280311 · Cited by 81
Nolan, D. A., Watts, G. F., Herrmann, S., French, M. A., John, M., & Mallal, S. A. (2003) · QJM · doi:10.1093/qjmed/hcg145 · Cited by 63
Interactions between endothelial cells and HIV-1
Bussolino, F. (2001) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/s1357-2725(01)00024-3 · Cited by 62
Endothelial function in HIV-infected patients with low or mild cardiovascular risk
Blanco, J. J. R. (2006) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkl190 · Cited by 48
Shankar, S. S., & Dubé, M. P. (2004) · Cardiovascular Toxicology · doi:10.1385/ct:4:3:261 · Cited by 38
Self-citationLopinavir‐Ritonavir: Effects on Endothelial Cell Function in Healthy Subjects
Grubb, J. R., Dejam, A., Voell, J., Blackwelder, W. C., Sklar, P. A., Kovacs, J. A., Cannon, R. O., Masur, H., & Gladwin, M. T. (2006) · The Journal of Infectious Diseases · doi:10.1086/503807 · Cited by 31
Young, E. M., Considine, R. V., Sattler, F. R., Deeg, M. A., Buchanan, T. A., Degawa‐Yamauchi, M., Shankar, S. S., Edmondson‐Melançon, H., Hernández, J. E., & Dubé, M. P. (2004) · Cardiovascular Toxicology · doi:10.1385/ct:4:2:179 · Cited by 12
Self-citation
Cited by
. Inflammatory and coagulation biomarkers and mortality in patients with HIV infection.
Kuller, L. H., Tracy, R., Belloso, W., Wit, S. D., Drummond, F., Lane, H. C., Ledergerber, B., Lundgren, J., Neuhaus, J., Nixon, D., et al. (2008) · PLoS Medicine · doi:10.1371/journal.pmed.0050203 · Cited by 1,617
HIV Infection and the Risk of Acute Myocardial Infarction
Freiberg, M. S., Chang, C.-C. H., Kuller, L. H., Skanderson, M., Lowy, E., Kraemer, K. L., Butt, A. A., Bidwell Goetz, M., Leaf, D., Oursler, K. A., et al. (2013) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2013.3728 · Cited by 1,340
Immunologic Basis of Cardiovascular Disease in HIV-Infected Adults
Hsue, P. Y., Deeks, S. G., & Hunt, P. W. (2012) · The Journal of Infectious Diseases · doi:10.1093/infdis/jis200 · Cited by 269
HIV and Coronary Heart Disease
Boccara, F., Lang, S., Meuleman, C., Ederhy, S., Mary-Krause, M., Costagliola, D., Capeau, J., & Cohen, A. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.06.063 · Cited by 262
Inflammation, Immune Activation, and CVD Risk in Individuals With HIV Infection
Stein, J. H., & Hsue, P. Y. (2012) · JAMA · doi:10.1001/jama.2012.8488 · Cited by 94
Self-citation
Metadata
- Authors
- Torriani, F. J., Komarow, L., Parker, R. A., Cotter, B. R., Currier, J. S., Dubé, M. P., Fichtenbaum, C. J., Gerschenson, M., Mitchell, C. K. C., Murphy, R. L., Squires, K., & Stein, J. H.
- Venue
- Journal of the American College of Cardiology
- Publisher
- Elsevier BV
- Published
- 2008-08
- Volume
- 52
- Issue
- 7
- Pages
- 569-576
- ISSN
- 0735-1097 (ISSN-L)
- OpenAlex
- W138587671
- Cited by
- 300
- References
- 31
- FWCI
- 27.52
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.